Passer à la navigation principale Passer à la recherche Passer au contenu principal

Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness

  • Etienne Dardenne
  • , Sandra Pierredon
  • , Keltouma Driouch
  • , Lise Gratadou
  • , Magali Lacroix-Triki
  • , Micaela Polay Espinoza
  • , Eleonora Zonta
  • , Sophie Germann
  • , Hussein Mortada
  • , Jean Philippe Villemin
  • , Martin Dutertre
  • , Rosette Lidereau
  • , Stéphan Vagner
  • , Didier Auboeuf
  • INSERM U869
  • Institut Curie

Résultats de recherche: Contribution à un journalArticleRevue par des pairs

Résumé

Both epigenetic and splicing regulation contribute to tumor progression, but the potential links between these two levels of gene-expression regulation in pathogenesis are not well understood. Here, we report that the mouse and human RNA helicases Ddx17 and Ddx5 contribute to tumor-cell invasiveness by regulating alternative splicing of several DNA-and chromatin-binding factors, including the macroH2A1 histone. We show that macroH2A1 splicing isoforms differentially regulate the transcription of a set of genes involved in redox metabolism. In particular, the SOD3 gene that encodes the extracellular superoxide dismutase and plays a part in cell migration is regulated in an opposite manner by macroH2A1 splicing isoforms. These findings reveal a new regulatory pathway in which splicing factors control the expression of histone variant isoforms that in turn drive a transcription program to switch tumor cells to an invasive phenotype.

langue originaleAnglais
Pages (de - à)1139-1146
Nombre de pages8
journalNature Structural and Molecular Biology
Volume19
Numéro de publication11
Les DOIs
étatPublié - 1 janv. 2012
Modification externeOui

Empreinte digitale

Examiner les sujets de recherche de « Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation